Editorial content

BioPharma Dealmakers September 2015 edition

The September edition of BioPharma Dealmakers has feature articles and company profiles based upon the areas of CNS, the human microbiome and diseases of the aging.

Go to the profile of Raveena Bhambra
Nov 05, 2015
3
0

Read the September 2015 edition of BioPharma Dealmakers...


Read about the companies looking for partnerships from our September edition -

Astrocyte Pharmaceuticals Inc

Sanford Burnham Prebys Medical Discovery Institute

Bioasis

Teva Pharmaceuticals

Imanova Ltd

Institut Pasteur

Titan Pharmaceuticals

Probiodrug

Re-pharm

International Stem Cell Corporation

Read the in-depth partnering features from our September edition -

Advances in neuroscience and surging markets could signal deal spree

Manipulating the human microbiome to fight inflammatory disorders

Approaches to age-related disorders evolve

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.